The document discusses India's pharmaceutical industry, including its current size and growth rate. It notes that formulations make up 79% of the industry while bulk drugs account for 21%. The background section outlines how India's Patents Act of 1970 only recognized process patents and led to increased domestic production. It also discusses how India transitioned to a product patent regime in 2005 to comply with TRIPS and how this has impacted multinational companies investing in India.

1. A Report Brakes India Limited December 20, 2007 india’s pharmaceutical industry STATUS & ISSUES…

2. Current Scenario India’s Pharmaceutical Market Size 3.55 4.15 4.39 5.13 5.7 6.41 4.69 9.48 Projected to grow at 13.6%CAGR Source: ASSOCHAM, Cygnus Study In USD Billion

3. Current Scenario Trend of India’s Pharmaceutical Export 97.5 128.3 152.1 178.6 222.2 Source: Director General of Commerce Intelligence In Rs Billion

4. Current Scenario Bulk drugs Generics Branded Drugs Copies of off-patent unbranded drugs Formulations

5. Current Scenario Formulations 79% Bulk Drugs 21% COMPO SITION OF INDIAN PHARMA INDUSTRY

7. Changing Business Models

11. Thank you…